Clinical Trial Update: Study of Pregabalin in the Prevention of Central Neuropathic Pain in Acute Spinal Cord Injury [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating pregabalin for preventing central neuropathic pain after acute spinal cord injury was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Spinal Cord Trauma, Pain | Phase 3 | Status: TERMINATED